Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference

        Print
| Source: Idenix Pharmaceuticals

CAMBRIDGE, Mass., Feb. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat discussion at the 2014 Leerink Global Healthcare Conference on Thursday, February 13, 2014, at 10:45 a.m. Eastern Time at the Waldorf Astoria Hotel in New York, NY.

The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

ABOUT IDENIX

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical Company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C infection. For further information about Idenix, please refer to www.idenix.com.

Idenix Pharmaceuticals Contact:
Teri Dahlman
(617) 995-9807